1 Jinwei W, Luxia Zhang, Chi-Wai TS et al. Disease burden and challenges of chronic kidney disease in North and East Asia. Kidney Int 2018; 94: 22-25.
2 Luxia Z, Fang W, Li W et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815-822.
3 Levey A S, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259.
4 Rule Andrew D, Lieske John C. The estimated glomerular filtration rate as a test for chronic kidney disease: problems and solutions. Cleve Clin J Med 2011; 78: 186-188.
5 Committee for the Korean Guidelines for the Management of Dyslipidemia,2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary. Korean Circ J 2016; 46: 275-306.
6 Varady Krista A, Jones Peter J H. Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels? J. Nutr. 2005; 135: 1829-1835.
7 Expert DP, Grundy SM. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia. J Clin Lipidol 2013; 7: 561-565.
8 Moorhead JF, Chan MK, El-Nahas M et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; 2: 1309-1311.
9 Gyebi L, Soltani Z, Reisin E. Lipid nephrotoxicity: new concept for an old disease. Curr. Hypertens. Rep. 2012; 14: 177-181.
10 Xiongzhong R, Varghese Z, Moorhead JF.An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol 2009; 5: 713-721.
11 Tozawa M, Iseki K, Iseki C et al. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 2002; 62: 1743-1749.
12 Kitiyakara C, Yamwong S, Cheepudomwit S et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int. 2007; 71: 693-700.
13 Metcalf P, Baker J, Scott A et al. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin. Chem. 1992; 38: 1802-1808.
14 Astor BC, Coresh J, Heiss G et al. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart J. 2006; 151: 492-500.
15 Cusick M, Chew EY, Hoogwerf B et al. Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26. Kidney Int. 2004; 66: 1173-1179.
16 Schaeffner E , Kurth T , Curhan G et al. Cholesterol and the risk of renal dysfunction in apparently healthy men.[J]. Archives of Internal Medicine, 2003, 14(9):1048-1053.
17 Yingchun M, Li Z, Jianghua C et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 2006; 17: 2937-2944.
18 Meiyu Y, Kang H, Juan J et al. The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study. BMC Nephrol 2018; 19: 190.
19 Chang YC, Hua SC, Chang CH et al. High TSH Level within Normal Range Is Associated with Obesity, Dyslipidemia, Hypertension, Inflammation, Hypercoagulability, and the Metabolic Syndrome: A Novel Cardiometabolic Marker. J Clin Med 2019; 8: 817.
20 Mänttäri M, Tiula E, Alikoski T et al. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995; 26: 670-675.
21 Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997; 51: 1908-1919.
22 Jiayu D, Chongjian W, Dongwei L et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey. Sci Rep 2019; 9: 10408.
23 Moafi M, Assadi F, Heshmat R et al. Impact of dyslipidemia on estimated glomerular filtration rate in apparently healthy children and adolescents: the CASPIAN-V study. World J Pediatr 2019, 15: 471-475.
24 Kuma A, Uchino B, Ochiai Y et al. Impact of low-density lipoprotein cholesterol on decline in estimated glomerular filtration rate in apparently healthy young to middle-aged working men. Clin. Exp. Nephrol. 2018; 22: 15-27.
25 Shimizu M, Furusyo N, Mitsumoto F et al. Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS). Atherosclerosis 2015; 238: 207-212.
26 Tsuruya K, Yoshida H, Nagata M et al. Association of Hypertriglyceridemia With the Incidence and Progression of Chronic Kidney Disease and Modification of the Association by Daily Alcohol Consumption. J RenNutr 2017; 27: 381-394.
27 Iseki K, Ikemiya Y, Fukiyama K et al. Serum cholesterol and risk of end-stage renal disease in a cohort of mass screening. Clin Exp Nephrol 1998; 2:18–24.